Pittsburgh (KDKA) – Scientists at the University of Pittsburgh have isolated a biomolecule that “completely and specifically” neutralizes the virus that causes coronovirus.
Researchers at the University of Pittsburgh School of Medicine have isolated the smallest biological molecule to date that neutralizes the SARS-CoV-2 virus, according to a report published Monday in the journal Cell. The report states that the antibody component is 10 times smaller than a full-size antibody and is used to make a drug called AB8 to be used as a therapeutic and preventive against SAR-COV-2.
Researchers report that AB8 is “highly effective” in preventing and treating SARS-CoV-2 infection in mice and hamsters.
“Ab8 not only has potential as a therapy for COVID-19, but it can also be used to help people get SARS-CoV-2 infection,” co-author John Mellors, MD, who at UPMC infectious diseases Is the head of the division of. And Pitt, said in a release from UPMC. “Large-sized antibodies have worked against and tolerate other infectious diseases, we hope that this can be an effective treatment for patients with COVID-19 and to protect those who ever have Not infected and not immune. ”
Stay tuned with KDKA to learn more about this developing story.